Status:

UNKNOWN

Atrial Fibrillation in Relationship to Sleep Quality and Plasma Biomarkers

Lead Sponsor:

Premedix Academy

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Brief Summary

A. Compare the plasmatic biomarkers between the cohort with and without AFib. B. Find sensitive and specific biomarkers that could be used for the diagnostic management of AFib. C. Compare the quali...

Detailed Description

AFib is the most common sustained arrhythmia, associated with an increased risk of stroke, heart failure, and mortality. Despite the high prevalence, AFib may be asymptomatic and consequently subclini...

Eligibility Criteria

Inclusion

  • The specific criteria for inclusion in the study group are:
  • Age \>17 years
  • Documented, nonvalvular paroxysmal AFib in the duration of more than 6 min. (medical history or ECG monitoring)
  • CHA2DS2-VASc score \> 2 for males
  • CHA2DS2-VASc score \> 3 for females
  • Sinus rhythm at the time of inclusion
  • The specific criteria for inclusion in the control group are:
  • No history of palpitations
  • AFib exclusion with the 7 days ECG Holter and ECG event recorder monitoring
  • Propensity matching

Exclusion

  • Exclusion criteria for both groups:
  • Electrical cardioversion less than 7 days prior to inclusion
  • Acute coronary syndrome less than 1 month prior to inclusion
  • Cardiac surgery less than 3 months prior to inclusion
  • Acute or decompensated heart failureat the time of inclusion
  • Pregnancy
  • Cardiomyopathy
  • Alcoholism (≥ 8 drinks/week)
  • Thyrotoxicosis
  • Renal Disease (Dialysis/ transplant/CrCl \< 0,5ml/s)
  • Liver disease (cirrhosis/ transaminase \> 3x ULT/ bilirubin \> 2x ULT)
  • Mechanical proshetic valves
  • Severe mitral stenosis
  • Class I and IV antiarrhythmic drugs usage in last month
  • Class III antiarrhythmic drugs usagein last 3 months

Key Trial Info

Start Date :

April 11 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2019

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03855540

Start Date

April 11 2018

End Date

December 31 2019

Last Update

March 29 2019

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Allan Bohm

Bratislava, Slovakia, 81102

2

East Slovak Institute of Cardiovascular Diseases

Košice, Slovakia

3

Hospital

Malacky, Slovakia

4

University hospital

Nitra, Slovakia